Abstract
Aims: To assess the influence of hip disease on the risk of revision, we studied different disease groups among 53 698 primary total hip replacements (THRs) reported to the NAR between 1987 and 1999. Methods: the revision rate in the 8 most common hip diseases were compared by kaplan-meier survival analyses and cox multiple-regression. To eliminate the influence of prosthesis type a subgroup of 16217 charnley prostheses were analysed. Results: we found statistically significant differences in prosthesis survival among the hip diseases, but after adjustment for prosthesis type most of the differences disappeared. In patients ≤60 years, 59% of the prostheses were uncemented and 33% could be defined as inferior uncemented prostheses. In the charnley subgroup only complications after fracture of the femoral neck had an increased risk for revision compared to primary osteoarthritis (rr 1.5, p=0.005). 10 years survival for cemented charnley prostheses with osteoarthritis was 92.0% for patients ≤60 years and 93.5% for patients > 60 years. Conclusions: after adjustment the results for all disease groups were good. The results of thrs in disease-groups where patients are operated on at a young age were less good because these patients had often been given inferior uncemented prostheses.
Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.